Glycosaminoglycan synthesis in fibroblasts (Homo sapiens)
From WikiPathways
Description
Glycosaminoglycans (GAGs) are key components of the extracellular matrix secreted by fibroblasts. This pathway shows the metabolic reactions necessary to synthesize three types of GAGs, namely chondroitin sulfate, dermatan sulfate and heparan sulfate. The synthesis takes place in the Golgi apparatus and begins with UDP-α-D-xylose. After this molecule is converted to 3-β-D-glucosyluronate-3-β-D-galactosyl-4-β-D-galactosyl-O-β-D-xylosyl-[protein] via three metabolic reactions, the pathway separates into two branches. One of them leads to the synthesis of chondroitin sulfate and dermatan (di)sulfate, while the other ends with heparan mono-, bi- or trisulfate. Some of the reactions are catalyzed by unknown enzymes that should be researched in the future.
This pathway was created based on the information from the pathways found in MetaCyc and HumanCyc databases (see Bibliography). As some of the metabolites do not have identifiers in databases supported by PathVisio (such as ChEBI or KEGG), their MetaNetX IDs were added in the comments.
Quality Tags
Ontology Terms
Bibliography
View all... |
- Caspi R; ''Pathway: chondroitin biosynthesis''; https://biocyc.org/HUMAN/NEW-IMAGE?type=PATHWAY&object=PWY-6566, 2010
- Caspi R, Billington R, Keseler IM, Kothari A, Krummenacker M, Midford PE, Ong WK, Paley S, Subhraveti P, Karp PD; ''The MetaCyc database of metabolic pathways and enzymes - a 2019 update.''; Nucleic Acids Res, 2020 PubMed Europe PMC Scholia
- Caspi R; ''Pathway: heparan sulfate biosynthesis''; https://metacyc.org/META/NEW-IMAGE?type=PATHWAY&object=PWY-6558&detail-level=2, 2010
- Casale J, Crane JS; ''Biochemistry, Glycosaminoglycans''; https://www.ncbi.nlm.nih.gov/books/NBK544295/#:~:text=The%20process%20of%20GAG%20biosynthesis,and%20UDP%2DN%2Dacetylgalactosamine., 2023
- Caspi R; ''Pathway: dermatan sulfate biosynthesis''; , 2010
- Huang YF, Mizumoto S, Fujita M; ''Novel Insight Into Glycosaminoglycan Biosynthesis Based on Gene Expression Profiles.''; Front Cell Dev Biol, 2021 PubMed Europe PMC Scholia
- Caspi R; ''Pathway: chondroitin sulfate biosynthesis''; https://metacyc.org/META/NEW-IMAGE?type=PATHWAY&object=PWY-6567&detail-level=2, 2010
- Caspi R; ''Pathway: glycosaminoglycan-protein linkage region biosynthesis''; https://metacyc.org/META/NEW-IMAGE?type=PATHWAY&object=PWY-6557, 2010
- Basu A, Patel NG, Nicholson ED, Weiss RJ; ''Spatiotemporal diversity and regulation of glycosaminoglycans in cell homeostasis and human disease.''; Am J Physiol Cell Physiol, 2022 PubMed Europe PMC Scholia
- Caspi R; ''Pathway: superpathway of heparan sulfate biosynthesis''; https://metacyc.org/META/NEW-IMAGE?type=PATHWAY&object=PWY-6564&detail-level=2, 2010
- Karp PD, Billington R, Caspi R, Fulcher CA, Latendresse M, Kothari A, Keseler IM, Krummenacker M, Midford PE, Ong Q, Ong WK, Paley SM, Subhraveti P; ''The BioCyc collection of microbial genomes and metabolic pathways.''; Brief Bioinform, 2019 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
3-O-(β-D-xylosyl)-L-seryl-[protein] | Metabolite | C02399 (KEGG Compound) | |
3-β-D-galactosyl-4-β-D-galactosyl -O-β-D-xylosyl-[protein] | Metabolite | C04825 (KEGG Compound) | |
3-β-D-glucosyluronate-3-β-D-galactosyl -4-β-D-galactosyl-O-β-D-xylosyl-[protein] | Metabolite | 80007 (ChEBI) | |
3-β-D-glucosyluronate-3-β-D-galactosyl -4-β-D-galactosyl-O-β-D-xylosyl-[protein] | Metabolite | C04903 (KEGG Compound) | |
4-β-D-galactosyl-O-β-D-xylosyl-[protein] | Metabolite | 25245405 (PubChem-compound) | |
B3GALT6 | GeneProduct | ENSG00000176022 (Ensembl) | |
B3GAT1 | GeneProduct | ENSG00000109956 (Ensembl) | |
B3GAT2 | GeneProduct | ENSG00000112309 (Ensembl) | |
B3GAT3 | GeneProduct | ENSG00000149541 (Ensembl) | |
B4GALT7 | GeneProduct | ENSG00000027847 (Ensembl) | |
CHPF2 | GeneProduct | ENSG00000033100 (Ensembl) | |
CHPF | GeneProduct | ENSG00000123989 (Ensembl) | |
CHST11 | GeneProduct | ENSG00000171310 (Ensembl) | |
CHST12 | GeneProduct | ENSG00000136213 (Ensembl) | |
CHST13 | GeneProduct | ENSG00000180767 (Ensembl) | |
CHST14 | GeneProduct | ENSG00000169105 (Ensembl) | |
CHST15 | GeneProduct | ENSG00000182022 (Ensembl) | |
CHST1 | GeneProduct | ENSG00000175264 (Ensembl) | |
CHST3 | GeneProduct | ENSG00000122863 (Ensembl) | |
CHST7 | GeneProduct | ENSG00000147119 (Ensembl) | |
CHSY1 | GeneProduct | ENSG00000131873 (Ensembl) | |
CHSY3 | GeneProduct | ENSG00000198108 (Ensembl) | |
CSGALNACT1 | GeneProduct | ENSG00000147408 (Ensembl) | |
CSGALNACT2 | GeneProduct | ENSG00000169826 (Ensembl) | |
Chondroitin-[core protein] | Metabolite | 16137 (ChEBI) | |
DSE | GeneProduct | ENSG00000111817 (Ensembl) | |
Deacetylated heparosan-[core protein] | Metabolite | C02834 (KEGG Compound) | |
Dermatan-NAcGal-4-sulfates | Metabolite | MetaNetX: MXNM96191 | |
Dermatan-NAcGal-46-disulfates | Metabolite | MetaNetX: MXNM96257 | |
Dermatan-Sulfate | Metabolite | 18376 (ChEBI) | |
Dermatan-[core protein] | Metabolite | 4439 (ChEBI) | |
Dermatan-sulfate-L-IdoA2S | Metabolite | MetaNetX: MNXM7277 | |
EXT1 | GeneProduct | ENSG00000182197 (Ensembl) | |
EXT2 | GeneProduct | ENSG00000151348 (Ensembl) | |
EXTL1 | GeneProduct | ENSG00000158008 (Ensembl) | |
EXTL2 | GeneProduct | ENSG00000162694 (Ensembl) | |
EXTL3 | GeneProduct | ENSG00000012232 (Ensembl) | |
GLCE | GeneProduct | ENSG00000138604 (Ensembl) | |
GalNAc-GlcA-Gal-Gal-Xyl-Proteins | Metabolite | MetaNetX: MXNM18007 | |
GalNAc-GlcA-GalNAc- GlcA-Gal-Gal-Xyl-Pr | Metabolite | MetaNetX: MXNM148368 | |
GlcA-GalNAc-GlcA-Gal-Gal-Xyl-Proteins | Metabolite | MetaNetX: MXNM148183 | |
GlcA-GlcNAc-GlcA-Gal-Gal-Xyl-Protein | Metabolite | MetaNetX: MNXM148103 | |
GlcNAc-GlcA-GlcNAc-GlcA -Gal-Gal-Xyl-Core | Metabolite | MetaNetX: MNXM148048 | |
HS2ST1 | GeneProduct | ENSG00000153936 (Ensembl) | |
HS3ST1 | GeneProduct | ENSG00000002587 (Ensembl) | |
HS3ST2 | GeneProduct | ENSG00000122254 (Ensembl) | |
HS3ST3A1 | GeneProduct | ENSG00000153976 (Ensembl) | |
HS3ST3B1 | GeneProduct | ENSG00000125430 (Ensembl) | |
HS6ST1 | GeneProduct | ENSG00000136720 (Ensembl) | |
HS6ST2 | GeneProduct | ENSG00000171004 (Ensembl) | |
HS6ST3 | GeneProduct | ENSG00000185352 (Ensembl) | |
Heparan-Glc-N-3-6-trisulfate | Metabolite | MetaNetX: MNXM18334 | |
Heparan-GlcN-6-N-bisulfate | Metabolite | MetaNetX: MNXM11794 | |
Heparan-sulfate-3-N-disulfate | Metabolite | MetaNetX: MNXM8703 | |
Heparan-sulfate-L-IdoA-2S | Metabolite | MetaNetX: MNXM96199 | |
Heparosan-[core protein] | Metabolite | 24500 (ChEBI) | |
NDST1 | GeneProduct | ENSG00000070614 (Ensembl) | |
NDST2 | GeneProduct | ENSG00000166507 (Ensembl) | |
NDST3 | GeneProduct | ENSG00000164100 (Ensembl) | |
NDST4 | GeneProduct | ENSG00000138653 (Ensembl) | |
UDP-N-acetyl-α-D-galactosamine | Metabolite | 67138 (ChEBI) | |
UDP-α-D-galactose | Metabolite | 66914 (ChEBI) | |
UDP-α-D-glucuronate | Metabolite | 58052 (ChEBI) | |
UDP-α-D-xylose | Metabolite | 57632 (ChEBI) | |
UST | GeneProduct | ENSG00000111962 (Ensembl) | |
XYLT1 | GeneProduct | ENSG00000103489 (Ensembl) | |
XYLT2 | GeneProduct | ENSG00000015532 (Ensembl) | |
[Heparan sulfate] containing GlcNS | Metabolite | 13555 (ChEBI) | |
[Heparosan]-containing α-L-iduronate | Metabolite | 17174 (ChEBI) | |
chondroitin 4'-sulfate | Metabolite | 18250 (ChEBI) | |
chondroitin 6'-sulfate | Metabolite | 18296 (ChEBI) | |
heparin-glucosamine-3-O-sulfate | Metabolite | C04072 (KEGG Compound) |
Annotated Interactions
No annotated interactions